Market Place
Sourcing Support
Boehringer cuts monthly out-of-pocket inhaler prices to $35 for US patients
08 Mar 2024 //
FIERCE PHARMA
Lupin Launches Tiotropium Dry Powder for Inhaler for the Treatment of COPD
16 Aug 2023 //
PR NEWSWIRE
Lupin Announces Health Canada Approval of Tiotropium Bromide Inhalation Powder
11 Jul 2023 //
PR NEWSWIRE
Lupin wins first FDA approval for generic version of blockbuster Spiriva
22 Jun 2023 //
ENDPTS
Lupin`s Generic (Tiotropium Bromide) Receives Approval in the U.S.
20 Jun 2023 //
FDA
Lupin gets Health Canada marketing approval for generic Spiriva to treat COPD
27 May 2023 //
PHARMABIZ
Lupin Announces Health Canada Approval of Tiotropium Bromide for COPD
27 May 2023 //
PRESS RELEASE
FDA Confirms Paragraph IV Patent Litigation for Tiotropium Bromide
18 May 2023 //
FDA
Lupin`s arm gets UK regulator nod for COPD treatment
25 Aug 2022 //
ECONOMIC TIMES
Glenmark Pharma launches Tavulus for COPD treatment in Spain
11 Oct 2021 //
PHARMABIZ
Like a drop in the ocean
04 Feb 2020 //
PRESS RELEASE
New Study Further Supports the Benefits of SPIRIVA RESPIMAT
03 Feb 2020 //
PR NEWSWIRE
Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study
13 Jan 2020 //
PRESS RELEASE
Boehringer Ingelheim Announces First Patient Enrolled in Phase II Trial
16 Oct 2019 //
BUSINESSWIRE
FDA fast-tracks BI, Lilly`s Jardiance in chronic heart failure
26 Jun 2019 //
FIERCE PHARMA
Boehringer Ingelheim opens inhaler plant with 200 jobs
18 Jun 2019 //
FIERCE PHARMA
Boehringer eyes rare disease use for respiratory blockbuster
21 May 2019 //
PMLIVE
With Spiriva under pressure, Boehringer moves to bolster pipeline
18 Apr 2019 //
PMLIVE
Amgen, GSK advance to #FierceMadness Elite 8
27 Mar 2019 //
FIERCE PHARMA
Spiriva (Tiotropium bromide): Boehringer Ingelheim vs. Lupin
02 Dec 2018 //
PATENT LITIGATION
Boehringer v Teva: Italian court clarifies boundaries of Bolar privilege
09 Nov 2018 //
LIFESCIENCES IPR
FDA Approves Stiolto® Respimat® sNDA to Add Data on COPD Exacerbation Reduction
11 Oct 2018 //
PR NEWSWIRE
Theravance Biopharma and Mylan Report +ve New Data of Studies of YUPELRI
11 Oct 2018 //
PR NEWSWIRE
FDA Approves Stiolto® Respimat® sNDA to Add Data on COPD Exacerbation Reduction
11 Oct 2018 //
PR NEWSWIRE
Theravance Biopharma and Mylan Report +ve New Data of Studies of YUPELRI
11 Oct 2018 //
PR NEWSWIRE
FDA Approves Stiolto® Respimat® sNDA to Add Data on COPD Exacerbation Reduction
11 Oct 2018 //
PR NEWSWIRE
Theravance Biopharma and Mylan Report +ve New Data of Studies of YUPELRI
11 Oct 2018 //
PR NEWSWIRE
Boehringer Ingelheim announces study results of Spiolto Respimat trial
17 Sep 2018 //
MEDICAL NEWS
Glenmark inks licensing pact for Tiotropium Bromide in W-Europe
29 Aug 2018 //
ECONOMIC TIMES
Spiriva (Tiotropium bromide) : Boehringer Ingelheim Pharmaceuticals v. Lupin Ltd
13 Aug 2018 //
PATENT LITIGATION
Boehringer’s Spiriva gets UK license for young asthma patients
08 Jun 2018 //
PHARMA TIMES
Enforcement Report - Week of February 7, 2018
07 Feb 2018 //
FDA
Asthma’s a real bear in Boehringer new TV campaign for Spiriva Respimat
03 Oct 2017 //
FIERCE PHARMA
New Analyses Show SPIRIVA® RESPIMAT® (tiotropium bromide)
23 May 2017 //
PR NEWSWIRE
Glenmark gets USFDA nod to start phase-II clinical trials for respiratory drug
07 Mar 2017 //
LIVEMINT
US FDA approves expanded indication for Boehringer Ingelheim’s, Spiriva Respimat
17 Feb 2017 //
PHARMABIZ
FDA Expands Approval of Spiriva Respimat Inhalation Spray
17 Feb 2017 //
PR NEWSWIRE
Harvoni, Lantus top Medicare, Medicaid drug spend as U.S. total hits $457B
15 Nov 2016 //
FIERCE PHARMA
STIOLTO RESPIMAT tiotropium bromide,olodaterol Inhalation Spray Improvd Capacity
05 Sep 2016 //
PR NEWSWIRE
Boehringer starts to feel impact of Spiriva generics
03 Aug 2016 //
PMLIVE
New Analyses: Adding SPIRIVA® RESPIMAT® Effective for Uncontrolled Asthma
07 Mar 2016 //
PR NEWSWIRE
SPIRIVA RESPIMAT Now Available in the U.S.
03 Feb 2016 //
PRNEWSWIRE
COPD Market Hit $9.2Bn in 2014 & Will Add $ Bn by 2021, says GBI Research
03 Dec 2015 //
PR NEWS WIRE
Obstacles aside, Boehringer sees class-topping prospects for Ofev, Spiolto
02 Oct 2015 //
FIERCE PHARMA MARKETING
Despite Generic Erosion of Current Market, Asthma Market Will Remain Steady
22 Sep 2015 //
PR NEWS WIRE
Three new drugs green-lighted for NHS Scotland
10 Aug 2015 //
PHARMA TIMES
Boehringer gets respiratory boost with batch of Spiolto nods in EU
02 Jul 2015 //
FIERCE PHARMA
Boehringer COPD combination approved in Europe
02 Jul 2015 //
PHARMA TIMES
Boehringer`s Sales Drop After `Intense And Challenging` Year
23 Apr 2015 //
PMLIVE
Germany`s Boehringer Loses India Patent on Lung Drug to Cipla
11 Mar 2015 //
REUTERS
German Firm Boehringer Ingelheim’s Patent for Asthma Drug Revoked
10 Mar 2015 //
THE ECONOMIC TIMES
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status
21 Feb 2015 //
PR NEWSWIRE
Mylan Inks $800m Women`s Health Deal, Theravance Alliance
04 Feb 2015 //
PHARMA TIMES
SPIRIVA RESPIMAT (tiotropium bromide) Inhalation Spray Now Available in the United States
21 Jan 2015 //
BOEHRINGER INGELHEIM
Top 20 Global Products 2014- IMS
29 Dec 2014 //
IMS HEALTH
